Pseudointernuclear ophthalmoplegia as a presenting feature of ocular myasthenia gravis

Britta Nijsse; Marijke Wefers Bettink; Rinze F Neuteboom

doi:10.1136/bcr-2013-203234

Pseudointernuclear ophthalmoplegia as a presenting feature of ocular myasthenia gravis

Britta Nijsse, Marijke Wefers Bettink, Rinze F Neuteboom

Ophthalmic Emergency Department

Onderzoeksoutput: Bijdrage aan tijdschrift › Brief › peer review

Originele taal-2	Engels
Tijdschrift	BMJ Case Reports
Volume	2014
DOI's	https://doi.org/10.1136/bcr-2013-203234
Status	Gepubliceerd - 13 jun. 2014

Toegang tot document

10.1136/bcr-2013-203234

Citeer dit

@article{4dbdeac6015d4d7890c24d7348e1ee5f,

title = "Pseudointernuclear ophthalmoplegia as a presenting feature of ocular myasthenia gravis",

keywords = "Adolescent, Cholinesterase Inhibitors/administration \& dosage, Drug Administration Schedule, Female, Humans, Myasthenia Gravis/complications, Nystagmus, Pathologic/drug therapy, Ophthalmoplegia/drug therapy, Pyridostigmine Bromide/administration \& dosage, Treatment Outcome",

author = "Britta Nijsse and \{Wefers Bettink\}, Marijke and Neuteboom, \{Rinze F\}",

year = "2014",

month = jun,

day = "13",

doi = "10.1136/bcr-2013-203234",

language = "English",

volume = "2014",

}

TY - JOUR

T1 - Pseudointernuclear ophthalmoplegia as a presenting feature of ocular myasthenia gravis

AU - Nijsse, Britta

AU - Wefers Bettink, Marijke

AU - Neuteboom, Rinze F

PY - 2014/6/13

Y1 - 2014/6/13

KW - Adolescent

KW - Cholinesterase Inhibitors/administration & dosage

KW - Drug Administration Schedule

KW - Female

KW - Humans

KW - Myasthenia Gravis/complications

KW - Nystagmus, Pathologic/drug therapy

KW - Ophthalmoplegia/drug therapy

KW - Pyridostigmine Bromide/administration & dosage

KW - Treatment Outcome

U2 - 10.1136/bcr-2013-203234

DO - 10.1136/bcr-2013-203234

M3 - Letter

C2 - 24928935

SN - 1757-790X

VL - 2014

JO - BMJ Case Reports

JF - BMJ Case Reports

ER -